Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potentials and possible pitfalls of human stem cell analysis

M L Rosenblum, D V Dougherty, C Reese

    Cancer Chemotherapy and Pharmacology
    |January 1, 1981
    PubMed
    Summary

    A novel clonogenic assay evaluates brain tumor cell sensitivity to BCNU, correlating with patient outcomes. This stem cell assay aids in understanding drug resistance and optimizing glioblastoma treatment strategies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Immunologic aspects of renal diseases.

    JAMA·1992
    Same author

    Magnetic resonance imaging of tuberculum sellae meningiomas: preventing preoperative misdiagnosis as pituitary macroadenoma.

    Neurosurgery·1992
    Same author

    Ontogeny of T lymphocyte function in the neonate.

    American journal of reproductive immunology (New York, N.Y. : 1989)·1992
    Same author

    Heparin decreases mesangial matrix accumulation after selective antibody-induced mesangial cell injury.

    Journal of the American Society of Nephrology : JASN·1992
    Same author

    Positron emission tomography for tumour assessment.

    NMR in biomedicine·1992
    Same author

    Radiosurgery: a new application?

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1992

    Area of Science:

    • Oncology
    • Cell Biology
    • Pharmacology

    Background:

    • Malignant brain tumors present challenges in predicting patient response to chemotherapy.
    • Understanding tumor heterogeneity and drug resistance mechanisms is crucial for effective treatment.
    • Existing assays may not fully capture in vivo drug sensitivity.

    Purpose of the Study:

    • To develop and validate a clonogenic cell assay for assessing brain tumor cell sensitivity to BCNU.
    • To correlate in vitro drug sensitivity with clinical patient response to BCNU.
    • To explore the potential of stem cell analysis in human tumors for personalized medicine.

    Main Methods:

    • Development of a clonogenic assay for malignant brain tumors.
    • Dissociation of representative single cells from solid tumors.
    • Optimization of culture conditions and characterization of colony growth.
    • In vitro drug exposure protocols designed to mimic in situ conditions.

    Main Results:

    • The developed assay successfully evaluates tumor cell sensitivity to BCNU.
    • Assay results show a correlation with patient response to BCNU treatment.
    • Demonstrated potential for stem cell analysis in understanding clinical drug failure.

    Conclusions:

    • The clonogenic assay provides a reliable method for predicting BCNU efficacy in brain tumors.
    • This assay facilitates the study of tumor stem cells and drug resistance.
    • Overcoming system errors can enhance the sensitivity and predictive value of such analytic methods.

    Related Experiment Videos